Ranitidine, the original active ingredient in Zantac, is not currently available in its original form in the United States. The FDA requested that all manufacturers withdraw ranitidine products from the market in April 2020 after testing revealed unacceptable levels of a cancer-linked contaminant called NDMA. That withdrawal remains in effect, and no traditional ranitidine product has returned to pharmacy shelves.
If you’ve seen “Zantac” at the store recently, you’re looking at a completely different medication. Here’s what you need to know about what happened, what replaced it, and where things stand.
Why Ranitidine Was Pulled in 2020
The FDA discovered that ranitidine could break down into a compound called NDMA (N-Nitrosodimethylamine), which is classified as a probable human carcinogen by both the FDA and the EPA. Every regulatory and scientific body that has evaluated NDMA agrees it causes cancer in animal studies, and the International Agency for Research on Cancer has warned since the 1970s that it should be treated as if it’s carcinogenic to humans.
The FDA set an acceptable daily intake limit for NDMA at 96 nanograms per day, or 0.32 parts per million for ranitidine products. Testing showed that ranitidine didn’t just contain NDMA as a manufacturing impurity. The molecule itself was unstable: NDMA levels in ranitidine tablets increased when stored at higher temperatures, and the longer a product sat on a shelf, the more NDMA it could generate. That instability problem made ranitidine fundamentally different from other contamination cases the FDA had handled before, and it led to the full market withdrawal rather than a limited recall.
What Zantac 360 Actually Contains
The product currently sold as “Zantac 360” is not ranitidine. It contains famotidine, the same active ingredient found in Pepcid. The over-the-counter version comes in 20 mg famotidine tablets labeled as an acid reducer. The name “Zantac” was kept as a brand, but the chemistry inside the pill is entirely different.
Famotidine and ranitidine both belong to the same drug class. They work by blocking the same type of receptor in the stomach lining that triggers acid production. In clinical comparisons, equally potent doses of famotidine lasted about 30% longer than ranitidine at suppressing acid. For most people with heartburn or mild reflux, famotidine handles the job ranitidine used to do. The key difference for safety purposes: famotidine does not have the NDMA instability problem that sank ranitidine.
The Ongoing Cancer Litigation
Thousands of lawsuits have been filed by people who took ranitidine for years and later developed cancer. The legal picture is complicated and still unfolding. A federal court in Florida dismissed many of the claims in a large multidistrict litigation, but courts in Delaware, California, and Illinois have reached different conclusions, allowing expert testimony on whether NDMA from ranitidine can cause cancer in humans.
The core scientific dispute in these cases is narrow but important. No regulatory body has ever specifically evaluated whether the NDMA exposure from taking ranitidine pills causes cancer. The FDA has said that NDMA itself is a probable carcinogen and warned that “sustained higher levels of exposure to NDMA from ranitidine could increase the risk of cancer,” but it stopped short of making a definitive causal link. Meanwhile, a 2020 study concluded that NDMA-contaminated ranitidine increases cancer risk, and a 2021 study found an association between ranitidine use and bladder cancer. These cases will likely continue for years.
Ranitidine Status Outside the U.S.
The withdrawal wasn’t limited to the United States. In September 2020, the European Medicines Agency recommended suspending all ranitidine medicines across the EU due to NDMA contamination, and the European Commission made that suspension legally binding in November 2020. That suspension remains in place. Canada similarly pulled ranitidine products. If you’re traveling or shopping internationally, you should not expect to find legitimate ranitidine products on pharmacy shelves in any major regulated market.
Your Options for Acid Relief
If you used to rely on ranitidine for heartburn or acid reflux, the most direct replacement is famotidine (sold as Pepcid or Zantac 360). It works through the same mechanism and lasts somewhat longer per dose. Cimetidine (Tagamet) is another option in the same drug class, though it has more potential for drug interactions than famotidine does.
For people who need stronger acid suppression than these medications provide, proton pump inhibitors like omeprazole (Prilosec) and esomeprazole (Nexium) are available over the counter and reduce acid production through a different pathway. These are more potent but come with their own considerations for long-term use, so they’re best discussed with a doctor if you’re taking them regularly rather than occasionally.
If you still have old ranitidine tablets at home, the FDA’s guidance is straightforward: do not take them. Dispose of them according to your pharmacy’s recommended disposal method rather than flushing them or simply tossing them in the trash.